Nyrada (ASX:NYR) Accounts Payable & Accrued Expense : A$0.27 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Nyrada Accounts Payable & Accrued Expense?

Nyrada's quarterly accounts payable & accrued expense declined from Dec. 2022 (A$1.07 Mil) to Jun. 2023 (A$0.72 Mil) and declined from Jun. 2023 (A$0.72 Mil) to Dec. 2023 (A$0.27 Mil).

Nyrada's annual accounts payable & accrued expense declined from Jun. 2021 (A$0.59 Mil) to Jun. 2022 (A$0.38 Mil) but then increased from Jun. 2022 (A$0.38 Mil) to Jun. 2023 (A$0.72 Mil).

Nyrada Accounts Payable & Accrued Expense Historical Data

The historical data trend for Nyrada's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyrada Accounts Payable & Accrued Expense Chart

Nyrada Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

0.28

0.70

0.59

0.38

0.72

Nyrada Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			0.39	0.38	1.07	0.72	0.27

Nyrada Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Nyrada (ASX:NYR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nyrada Inc (ASX:NYR) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

828 Pacific Highway, Suite 2, Level 3, Gordon, NSW, AUS, 2072

Website

https://www.nyrada.com

Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.

Nyrada (ASX:NYR) Headlines

No Headlines